Additionally, subgroup analyses indicated that overexpression of CENPF in ACC patients acted as a risk factor for 30-month, 60-month, and 120-month OS (all log-rank p ≤ 0.001, Fig. 4e–g). This evidence concerns the gene CENPF and adrenal cortex carcinoma.